Following the successful trial of a new malaria vaccine currently developed and tested in the United States, the United Nations Children Education Fund, (UNICEF), has described it as a welcome development. According to...
Thousands of adults in the U.S. suffer serious health problems or even die from vaccine-preventable diseases, the U.S. Centers for Disease Control and Prevention said on Thursday. The CDC said that few adults realize...
A team of researchers found an investigational malaria vaccine has to be safe, to generate an immune system response, and to offer protection against malaria infection in healthy adults. Malaria is transmitted to humans...
The GAVI Alliance has approved US$ 21 million to help improve vaccine supply chains in Nigeria as part of a partnership aimed at scaling up routine immunization. The funds will be used by Nigeria’s National...
Only a third of American teenage girls 13 to 17 were fully vaccinated against human papillomavirus virus (HPV) in 2012, a figure that declined somewhat in comparison with 2011, The New York Times reports. HPV is a main...
MAPS technology may generate vaccines conferring strong immunity at reduced cost and risk. A new method of vaccine design, called the Multiple Antigen Presentation System (MAPS), may result in vaccines that bring...
Private pharmaceutical companies importing vaccines will be required to submit a “Lot Release Certificate” from January 1, 2014 before marketing or selling in an attempt to streamline and ensure regulations are...
Not many may know that the Hepatitis-B is 100 times deadlier than HIV and claims around one lakh lives in India every yea, said Dr. Manoj Kumar Sahu, Associate Professor at the Centre of Excellence for Gastrointestinal...
The Costa Rica Vaccine Trial for human papillomavirus (HPV) in young women has had a “modest” impact on gynecologic outcomes in the first few years of the program. Data shows that the impact of vaccination on rates of...
A French pharmaceutical company says it hopes to have the first vaccine against dengue very soon. Sanofi Pasteur is finalising tests in Africa and Asia and plans to start producing the vaccine by the end of the year The...